跳至主要内容
临床试验/NCT04916015
NCT04916015招募中不适用

Comparative Study of the Histomolecular, Radiological and Prognostic Profiles Between Brain Gliomas of Children (0-14 Years) and Adolescents/Young Adults (15-25 Years) Treated in the Amiens University Hospital Between 2008 and 2020

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
130
试验地点
1
主要终点
Histogical glioma differences between child group(0-14 years) and AYA group (15-25 years)

研究概览

简要总结

In the last decades, many advances have been made in the field of genetic abnormalities of glial and glioneuronal brain tumors. In the 2016 World Health organization (WHO) Classification of Tumors of the Central Nervous System, the concept of "integrated" diagnosis emerged: histological and genetic/molecular features now define many entities. Since 2016, six updates have been published by the c-IMPACT-NOW (the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy- Not Official WHO) to develop and clarify the "integrated" diagnosis. In the future WHO 2021 Classification of Tumors of the Central Nervous System, "integrated" diagnoses will take up even more importance. Even if they can have similar histological features, gliomas of children are very different from the "adult" gliomas in the molecular mechanism of oncogenesis. The histomolecular features of adolescents/young adults (AYAs) can have similarities with "pediatric-type" or "adult-type" gliomas, but few studies have focused specifically on the histomolecular profiles of gliomas in AYAs.

The investigators would like to study the cohort of patients treated for a glial and glioneuronal tumor diagnosed under the age of 25 in the Amiens University Hospital between 2008 and 2020. The investigators would like to compare the histomolecular profiles of gliomas in children (0-14 years) and AYAs (15-25 years).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
— 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patient
  • Patient treated in the Amiens University Hospital
  • Patient treated for a glial or glioneuronal brain tumor according to the 2016 WHO Classification of Tumors of the Central Nervous System ("diffuse oligodendroglia or astrocytoma tumour," "another astrocytic tumor," "another glioma" or a "mixed neuronal or glioneuronal tumour").
  • Diagnosis histologically confirmed or formally established by radiologist.
  • Diagnosis established between January 1, 2008 and December 31,
  • No patient opposition (from adult patient, or from the holder of parental authority of the minor patient).

排除标准

  • Uncertain diagnosis
  • Patient opposition (from adult patient, or from the holder of parental authority of the minor patient).

结局指标

主要结局

Histogical glioma differences between child group(0-14 years) and AYA group (15-25 years)

时间窗: one year

Molecular glioma differences between child group(0-14 years) and AYA group (15-25 years)

时间窗: one year

次要结局

  • Variation of glioma MRI profile between child group(0-14 years) and AYA group (15-25 years)(one year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验